Buy Immunoglobulin complex preparation for enteral use (TRC) lyophilisate 300 mg 1 dose vials 5 pcs
  • Buy Immunoglobulin complex preparation for enteral use (TRC) lyophilisate 300 mg 1 dose vials 5 pcs

Human immunoglobulin normal IgG, IgA, IgM

Microgen NGO
Dosage form
Brand & Manufacturer
Package Size
$54.06
Quantity
There are not enough products in stock
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

KIP Immunoglobulin complex preparation increases specific immunity, increases the content of immunoglobulins and antibodies to enterobacteria (shigella, salmonella, escherichia, etc.).

Indications

Acute intestinal infections, dysbacteriosis (after exposure to radiation, chemotherapy), prevention of infectious diseases in persons with acquired immunodeficiency, immunocorrective therapy in children during the first years of life (premature, weakened, being artificially fed) and persons with reduced immune status (disabled, elderly) .

Composition

1 bottle contains immunoglobulin 300 mg (1 dose)

No customer reviews for the moment.

Write your review

Write your review

Human immunoglobulin normal IgG, IgA, IgM

Dosage and Administration

Orally, 30 minutes before a meal (pre-diluted powder in boiled water at room temperature: water is added to the contents of the bottle to half the volume and stirred with gentle shaking until a colorless transparent liquid is obtained - opalescence is allowed) 1-2 times a day for 5 days.

Adverse reactions

Polymorphic rash.

Contraindications

Allergic reaction (angioedema, rash, anaphylactic shock) to the introduction of human immunoglobulin in history.

Drug interactions

Perhaps a combination with antibiotics, synthetic chemotherapeutic drugs, bacteriophages.

Special instructions

If polymorphic rashes occur, treatment can be continued under the cover of antihistamines. Each introduction is registered in the established accounting forms with the indication of the series number, control number, expiration date, manufacturer, date of introduction and nature of the reaction to the introduction.

  • Brand name: Immunoglobulin complex preparation for enteral use (TRC)
  • Active ingredient: Human immunoglobulin normal IgG, IgA, IgM
  • Dosage form: Lyophilized powder for oral solution
  • Manufacturer: Microgen NGO
  • Country of Origin: Russia

Studies and clinical trials of Human immunoglobulin normal IgG, IgA, IgM (Click to expand)

  1. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice
  2. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes
  3. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)
  4. Development of immunocytes and immunoglobulin production in long-term cultures from normal and malignant human lymph nodes
  5. Differential in vitro effects of physiological and atmospheric oxygen tension on normal human peripheral blood mononuclear cell proliferation, cytokine and immunoglobulin production
  6. Mutual separation of hinge-glycopeptide isomers bearing five N-acetylgalactosamine residues from normal human serum immunoglobulin A1 by capillary electrophoresis
  7. Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites
  8. Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection
  9. Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora
  10. Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG
  11. Interaction of a Lymphokine with Normal Human Macrophages Results in Release of a Suppressor Factor for Mitogen-Induced Immunoglobulin Synthesis
  12. Immunoglobulin M in normal human serum is cytotoxic to polymorphonuclear neutrophils
  13. A Naturally Occurring Fragment Related to the Heavy Chains of Immunoglobulin G in Normal Human Urine
  14. Fc Fragment of Immunoglobulin G in Normal Human Plasma and Urine
  15. Characterization of the Fc′ Fragment of Immunoglobulin G in Normal Human Urine
  16. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals
  17. Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum
  18. Differential Regulatory Effects of cAMP-Elevating Agents on Human Normal and Neoplastic B Cell Functional Response Following Ligation of Surface Immunoglobulin and CD40
  19. Disulfide linking of albumin to the hinge region of immunoglobulin G in normal human serum
  20. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc
  21. Analysis of surface antigen expression of human immunoglobulin-secreting cells: phenotypic heterogeneity in normal counterparts of myeloma cells
  22. BIOLOGICAL VARIATION OF IMMUNOGLOBULIN CONCENTRATIONS IN NORMAL HUMAN TEARS RELATED TO AGE AND SEX
  23. Soluble HLA antigens in normal human immunoglobulin preparations

Customers who bought this product also bought:

8 other products in the same category:

arrow_upward